Sofinnova Investments, Inc. Nu Cana PLC Transaction History
Sofinnova Investments, Inc.
- $1.8 Billion
- Q2 2024
Shares
8 transactions
Others Institutions Holding NCNA
# of Institutions
4Shares Held
3.34MCall Options Held
0Put Options Held
0-
Abingworth LLP London, X03.33MShares$9.43 Million0.73% of portfolio
-
Ronald Blue Trust, Inc. Brentwood, TN2.22KShares$6,2820.0% of portfolio
-
Newbridge Financial Services Group, Inc.1.7KShares$4,8110.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.68KShares$4,7400.0% of portfolio
About NuCana plc
- Ticker NCNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,196,000
- Market Cap $148M
- Description
- NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...